近日从国家食品药品监督管理局了解到,为防止含麻黄碱类复方制剂流失进入制毒渠道,中国将在全国范围内开展药品类易制毒化学品专项整治。此次药品类易制毒化学品专项整治行动为期五个月,分动员部署、全面实施、总结评估三个阶段。专项整治行动将在全面加强药品类易制毒化学品管理的基础上,以含麻黄碱类复方制剂为重点品种,以流通环节为重点环节,全面加强药品类易制毒化学品和含麻黄碱类复方制剂管理,遏制药品类易制毒 Recently, the State Food and Drug Administration has learned that in order to prevent the loss of compound-containing compounds containing ephedrine into the channel of drug manufacture, China will carry out special rectification of precursor chemicals for pharmaceuticals across the country. The pharmaceutical precursor chemicals special rectification action for a period of five months, the mobilization of deployment, the full implementation of the assessment of the three stages. The special rectification action will be based on the comprehensive management of precursor chemicals for pharmaceuticals and the key varieties containing ephedrine-based compound preparations. Focusing on circulation, the Company will comprehensively strengthen its precursor chemicals and ephedrine-containing chemicals Class compound preparation management, to curb the drug easily precursor system